{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:49:46Z","timestamp":1770472186659,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101016167"],"award-info":[{"award-number":["101016167"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cmi.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T07:23:28Z","timestamp":1742628208000},"page":"S26-S36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients"],"prefix":"10.1016","volume":"31","author":[{"given":"Lorenzo Maria","family":"Canziani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Azzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Salmanton-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Savoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giulia","family":"Caponcello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeno","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livio","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Cingolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas Rodr\u00edguez","family":"Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Krampera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ilaria","family":"Del Principe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Farina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effrossyni","family":"Gkrania-Klotsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Liberatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Karofylakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaira R.","family":"Palacios-Baena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Paniagua-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Prezzavento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes Vazquez","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Pagnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Estefania","family":"Banegas Guallpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alda","family":"Strazimiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Vatteroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Simio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella d'Arminio","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Tincati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Piconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Pellican\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giordano","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Maria","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Lichtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Bonazzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milo","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Di Chiara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeno","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Olivares-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Ruda","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia Rodr\u00edguez","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Dolores","family":"Madrigal Toscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Dellacasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cataudella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.03.004_bib1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3201\/eid2908.221580","article-title":"Omicron COVID-19 case estimates based on previous SARS-CoV-2 wastewater load, regional municipality of Peel, Ontario, Canada","volume":"29","author":"Cheng","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-023-01423-7","article-title":"Passive pre-exposure immunization by tixagevimab\/cilgavimab in patients with hematological malignancy and COVID-19: Matched-paired analysis in the EPICOVIDEHA registry","volume":"16","author":"Marchesi","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cmi.2025.03.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102553","article-title":"Decoding the historical tale: COVID-19 impact on haematological malignancy patients\u2014EPICOVIDEHA insights from 2020 to 2022","volume":"71","author":"Salmanton-Garc\u00eda","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.cmi.2025.03.004_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/djad015","article-title":"COVID-19 severity by vaccination status in the NCI COVID-19 and cancer patients study (NCCAPS)","volume":"115","author":"Best","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cmi.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/s41375-024-02336-1","volume":"38","author":"Spanjaart","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.cmi.2025.03.004_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/cid\/ciae116","article-title":"Outcomes in hematopoietic cell transplant and chimeric antigen receptor T-Cell therapy recipients with pre\u2013cellular therapy SARS-CoV-2 infection","volume":"79","author":"Nimgaonkar","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib7","article-title":"Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy","volume":"30","author":"Infante","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.03.004_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31617","article-title":"SARS-CoV-2 infection, hospitalization, and mortality in adults with and without cancer","volume":"6","author":"Hosseini-Moghaddam","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2025.03.004_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/cid\/ciae291","article-title":"SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T-cell therapy: A prospective, multicenter, observational study","volume":"79","author":"Hill","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib10","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3324\/haematol.2021.280163","article-title":"Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: A systematic review and meta-analysis","volume":"107","author":"Gagelmann","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2025.03.004_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166032","article-title":"Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments","volume":"133","author":"Gupta","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cmi.2025.03.004_bib12","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/cid\/ciae026","article-title":"Clinical and virological outcome of monoclonal antibody therapies across SARS-CoV-2 variants in 245 immunocompromised patients: A multicenter prospective cohort study","volume":"78","author":"Huygens","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc2214302","article-title":"Efficacy of antiviral agents against omicron subvariants BQ.1.1 and XBB","volume":"388","author":"Imai","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2025.03.004_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110067","article-title":"Neutralization sensitivity of SARS-CoV-2 omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera","volume":"595","author":"Lee","year":"2024","journal-title":"Virology"},{"key":"10.1016\/j.cmi.2025.03.004_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12879-024-09631-3","article-title":"The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody","volume":"24","author":"Maruyama","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bjh.19143","article-title":"Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study","volume":"204","author":"Ichikawa","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2025.03.004_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ijc.34988","article-title":"Treatment of chronic COVID-19 with convalescent\/postvaccination plasma in patients with hematologic malignancies","volume":"155","author":"Janssen","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cmi.2025.03.004_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2021.101401","article-title":"Preparing, conducting, and analyzing Delphi surveys: Cross-disciplinary practices, new directions, and advancements","volume":"8","author":"Beiderbeck","year":"2021","journal-title":"MethodsX"},{"key":"10.1016\/j.cmi.2025.03.004_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100403","article-title":"Managing hematological cancer patients during the COVID-19 pandemic: An ESMO-EHA interdisciplinary expert consensus","volume":"7","author":"Buske","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.cmi.2025.03.004_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus reporting document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cmi.2025.03.004_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cmi.2025.03.004_bib24","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood.2022017257","article-title":"Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: Results from the EPICOVIDEHA survey","volume":"140","author":"Pagano","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41375-021-01424-w","article-title":"COVID-19 in patients with chronic lymphocytic leukemia: Clinical outcome and B- and T-cell immunity during 13 months in consecutive patients","volume":"36","author":"Blixt","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.cmi.2025.03.004_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.992137","article-title":"B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European hematology association survey (EPICOVIDEHA)","volume":"12","author":"Infante","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.cmi.2025.03.004_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.20411\/pai.v6i1.435","article-title":"COVID-19 outcomes in patients undergoing B cell depletion therapy and those with humoral immunodeficiency states: A scoping review","volume":"6","author":"Jones","year":"2021","journal-title":"Pathog Immun"},{"key":"10.1016\/j.cmi.2025.03.004_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100499","article-title":"COVID-19 in patients with cancer: First report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)","volume":"7","author":"Castelo-Branco","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.cmi.2025.03.004_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3324\/haematol.2022.280847","article-title":"COVID-19 in adult acute myeloid leukemia patients: A long-term follow-up study from the European hematology association survey (EPICOVIDEHA)","volume":"108","author":"Marchesi","year":"2022","journal-title":"Haematol"},{"key":"10.1016\/j.cmi.2025.03.004_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clml.2023.01.006","article-title":"Retrospective review of outcomes of multiple myeloma (MM) patients with COVID-19 infection (two-center study)","volume":"23","author":"Ehsan","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.cmi.2025.03.004_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125030","article-title":"Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry","volume":"14","author":"Busca","year":"2023","journal-title":"Front Immunol"},{"issue":"337","key":"10.1016\/j.cmi.2025.03.004_bib32","article-title":"High mortality of COVID-19 early after allogeneic stem cell transplantation: A retrospective multicenter analysis on behalf of the German cooperative transplant study group","volume":"28","author":"Schaffrath","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.03.004_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125824","article-title":"Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry","volume":"14","author":"Ljungman","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.03.004_bib34","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1038\/s41375-021-01466-0","volume":"35","author":"Spanjaart","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.cmi.2025.03.004_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/cac2.12453","article-title":"Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients","volume":"43","author":"Giuliano","year":"2023","journal-title":"Cancer Commun (Lond)"},{"issue":"398","key":"10.1016\/j.cmi.2025.03.004_bib36","article-title":"Severe acute respiratory syndrome coronavirus 2 vaccine immunogenicity among chimeric antigen receptor T cell therapy recipients","volume":"29","author":"Aleissa","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.03.004_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1169666","article-title":"Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: Predicting indicators of a high serologic response\u2014A prospective, single-arm study","volume":"14","author":"Barkhordar","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.03.004_bib38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/joim.13386","article-title":"Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients","volume":"291","author":"Martin-Vicente","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib39","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/bloodadvances.2021006937","article-title":"Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity","volume":"6","author":"Einarsdottir","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.cmi.2025.03.004_bib40","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jtct.2022.09.002","article-title":"Revised guidelines for coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022)","volume":"28","author":"Dioverti","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.03.004_bib41","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41375-023-01938-5","article-title":"Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European conference on infections in Leukaemia (ECIL 9)","volume":"37","author":"Cesaro","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.cmi.2025.03.004_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31053\/1853.0605.v80.n1.38171","article-title":"Descriptive analysis of cycle threshold in patients with hematologic malignancies infected with SARS-COV-2","volume":"80","author":"Santarelli","year":"2023","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"key":"10.1016\/j.cmi.2025.03.004_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jhin.2022.11.018","article-title":"Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: A systematic review","volume":"132","author":"Jefferson","year":"2023","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2025.03.004_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s15010-023-02138-0","article-title":"Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: A retrospective observational study in the Omicron era","volume":"52","author":"G\u00f6tz","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.03.004_bib45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmi.2024.03.027","article-title":"Stuck in pandemic uncertainty: A review of the persistent effects of COVID-19 infection in immune-deficient people","volume":"30","author":"Manuelpillai","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.03.004_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13000-023-01306-y","article-title":"What do we know about pathological mechanism and pattern of lung injury related to SARS-CoV-2 Omicron variant?","volume":"18","author":"Scendoni","year":"2023","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.cmi.2025.03.004_bib47","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib48","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe Covid-19 in outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40121-022-00729-2","article-title":"Efficacy and safety of nirmatrelvir\/ritonavir, molnupiravir, and remdesivir in a real-world cohort of outpatients with COVID-19 at high risk of progression: The PISA outpatient clinic experience","volume":"12","author":"Tiseo","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2025.03.004_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101939","article-title":"Nirmatrelvir\/ritonavir in COVID-19 patients with haematological malignancies: A report from the EPICOVIDEHA registry","volume":"58","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cmi.2025.03.004_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106952","article-title":"Molnupiravir compared to nirmatrelvir\/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry","volume":"62","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2025.03.004_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14006","article-title":"Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19","volume":"25","author":"Jabr","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib55","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/jac\/dkad105","article-title":"Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals","volume":"78","author":"Aiello","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"796","key":"10.1016\/j.cmi.2025.03.004_bib56","first-page":"e1","article-title":"Impact of SARS-CoV-2 in hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy recipients","volume":"27","author":"Mushtaq","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.03.004_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13576","article-title":"Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD","volume":"23","author":"Mirgh","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad306","article-title":"Successful treatment of persistent symptomatic coronavirus disease 19 infection with extended-duration Nirmatrelvir-Ritonavir among outpatients with hematologic cancer","volume":"10","author":"Liu","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib59","article-title":"COVID-19 Outcomes among hematopoietic cell transplant and chimeric antigen receptor T-cell recipients in the era of SARS-CoV-2 omicron variants and COVID-19 therapeutics","volume":"30","author":"Rosen","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.03.004_bib60","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3390\/antibiotics12091460","article-title":"Sequential or combination treatments as rescue therapies in immunocompromised patients with persistent SARS-CoV-2 infection in the omicron era: A case series","volume":"12","author":"Longo","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2025.03.004_bib61","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hon.3206","article-title":"Dual combined antiviral treatment with remdesivir and nirmatrelvir\/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection","volume":"41","author":"Pasquini","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cmi.2025.03.004_bib62","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajh.26209","article-title":"Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy","volume":"96","author":"Dul\u00e9ry","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cmi.2025.03.004_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1389345","article-title":"Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy","volume":"14","author":"Pi\u00f1ana","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.cmi.2025.03.004_bib64","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3389\/fonc.2020.01578","article-title":"Prolonged course of COVID-19-associated pneumonia in a B-cell depleted patient after rituximab","volume":"10","author":"Kos","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.cmi.2025.03.004_bib65","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.2021012443","article-title":"Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell\u2013directed therapies","volume":"138","author":"Ghione","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.03.004_bib66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bjh.17704","article-title":"COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies","volume":"195","author":"Passamonti","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2025.03.004_bib67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10096-024-04776-0","article-title":"Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy","volume":"43","author":"Feuth","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.004_bib68","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib69","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.3324\/haematol.2024.285875","article-title":"Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: Results from the EPICOVIDEHA registry","volume":"109","author":"Aiello","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2025.03.004_bib70","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.3390\/cancers14153711","article-title":"COVID-19 and adult acute leukemia: Our knowledge in progress","volume":"14","author":"Modemann","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cmi.2025.03.004_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/20406207231154706","article-title":"Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: Results from the EPICOVIDEHA registry","volume":"14","author":"Marchetti","year":"2023","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.cmi.2025.03.004_bib72","doi-asserted-by":"crossref","first-page":"E470","DOI":"10.1002\/ajh.26732","article-title":"Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19","volume":"97","author":"Barbui","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cmi.2025.03.004_bib73","doi-asserted-by":"crossref","DOI":"10.4212\/cjhp.3493","article-title":"Effect of JAK inhibitors on the risk of death in patients with moderate to severe COVID-19: A systematic review and meta-analysis of randomized controlled trials","volume":"77","author":"Kow","year":"2024","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.cmi.2025.03.004_bib74","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): A randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2025.03.004_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1117815","article-title":"Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine","volume":"13","author":"Palumbo","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.cmi.2025.03.004_bib76","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S1473-3099(23)00815-0","article-title":"Persistent SARS-CoV-2 infection: Significance and implications","volume":"24","author":"Machkovech","year":"2024","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25001223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25001223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:12:24Z","timestamp":1762366344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25001223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1198743X25001223"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.03.004","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}